Recursion Pharmaceuticals had a revenue of 5.17M in the quarter ending Sep 30, 2025, with -72.91%. This bring the company's revenue in the last twelve months to 43.53M, Increased -32.44%. In the fiscal year ending Dec 31, 2024, Recursion Pharmaceuticals had annual revenue of 58.84M with 32.00% growth.